RFA: Extramural Discovery Science Accelerator Award
The ACS EDS Accelerator Award funds key experiments to validate and de-risk ongoing cancer research technologies ready for commercialization and licensing.
Funder: American Cancer Society
Due Dates: June 1, 2026 | December 1, 2026
Funding Amounts: Up to $75,000 total costs for a one-year project; no indirect costs allowed.
Summary: Supports ongoing cancer research projects by funding key commercialization experiments to validate and de-risk technologies.
Key Information: Project must be ongoing and commercially driven with a clear plan for technology licensing; not for new research directions.
Description
The Extramural Discovery Science (EDS) Accelerator Award from the American Cancer Society is designed to help researchers commercialize ongoing cancer research by funding critical experiments needed to validate and de-risk technologies. The award specifically targets projects that do not fit into traditional grant mechanisms and are at a stage where commercialization is feasible. Projects must be commercially driven, with a defined plan to license the technology to an established company or start-up if successful. Awardees join an entrepreneurial learning community and receive support and educational programming from the ACS BrightEdge team.
